Phreesia
PHRPhreesia provides a comprehensive software, payments, and engagement platform designed to streamline healthcare delivery by managing patient access, affordability, and health outcomes.
Earnings
Q2 2027 report
September 2, 2026Next report
Dec 14, 2026 (in 2 months)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
Profile
Phreesia provides a comprehensive software, payments, and engagement platform designed to streamline healthcare delivery by managing patient access, affordability, and health outcomes. The company's cloud-based architecture integrates with existing provider workflows to automate administrative tasks, facilitate digital intake, and optimize financial performance for healthcare organizations.
Phreesia is a leading provider of patient intake and engagement solutions, facilitating approximately one in six ambulatory patient visits in the United States.
FAQ
- What is Phreesia's market cap?
- Phreesia (PHR) has a market capitalization of $661.7M and trades on NYSE.
- What is Phreesia's revenue and profitability?
- Phreesia generated $507.8M in trailing twelve-month revenue with net income of $10.4M, representing a net margin of 2.1%. Gross margin stands at 85.4%, with free cash flow of $80.7M. The latest reported period is Q2 2027.
- Who are Phreesia's competitors?
- Phreesia's key competitors include Veeva Systems, InfuSystem Holdings, Inc., Claritev Corporation, and others. These companies compete in similar markets and product categories.
- Who does Phreesia partner with?
- Phreesia's notable partners include Epic Systems, Oracle Health.
- What subsidiaries does Phreesia have?
- Phreesia's subsidiaries include AccessOne Parent Holdings, Inc., Insignia Health, MediFind.
- Where is Phreesia headquartered?
- Phreesia is headquartered in United States of America and employs approximately 1,438 people. It has been publicly traded since 2019.
